Halifax medical device maker ABK Biomedical has begun human trials for its Eye90 microspheres — tiny, mildly radioactive glass spheres visible on x-rays and CT scans, which can be injected into patients and used to view the size and shape of cancerous tumours.
The trial is being conducted in a partnership with the research unit of New Zealand’s Aukland Hospital. It is designed to test both the safety and effectiveness of the microspheres for liver and colon cancer patients. Each patient will be injected with the microspheres and then monitored for a year.
“We believe that Eye90 microspheres